Overexpression of P-gp is a well-established mechanism of chemoresistance in hematological cancers, including AML, ALL, diffuse large B-cell lymphoma, multiple myeloma, and follicular lymphoma. The gene discussed is PGP; the disease is acute lymphoblastic leukemia.